Healthcare & Pharmaceuticals
🟢 SERP-Grounded (Light Telemetry)

Zyrtec

Programmatic AI Search & Model Visibility Audit

Share of Model (SOM)
25.0%
-8.0% 30-Day Momentum
🧠 Neural Valency:Vulnerable

Algorithmic Threat Detection

Primary Competitor Threat
Claritin
Competitor Displacement Rate
30.0%

Competitors are displacing Zyrtec in 30.0% of high-intent buyer queries.

Algorithmic Rationale: Claritin and other newer antihistamines offer perceived advantages in non-drowsiness and efficacy. Zyrtec's market share is eroding due to competitive product advancements and marketing.
Missing AI Citations:
[claritin.com][allegra.com][webmd.com]
⚠️ Identified Vulnerability:Product Efficacy
Primary Threat Identified:Claritin
Target Persona:Allergy Sufferers
🚨 Threat Velocity:8/10
Unlock Full Threat Report (30 Free Credits)